Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Hummingbird TTS Ear Tube Delivery Study: Complete Statistical AnalysisIndependent statistical analysis of Hummingbird TTS Ear Tube Delivery Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02165384).
- HUPKIndependent statistical analysis of Pharmacokinetics of Oral Hydroxyurea Solution: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03763656).
- HVTN 120Independent statistical analysis of Evaluating the Safety and Immunogenicity of ALVAC-HIV and MF59®- or AS01B-adjuvanted Bivalent Subtype C gp120 in Healthy, HIV-uninfected Adult Participants: primary endpoint results, effect estimate with confidence interval,…
- HVTN 135Independent statistical analysis of Evaluating Safety and Immune Response to the HIV-1 CH505 Transmitted/Founder gp120 Adjuvanted With GLA-SE in Healthy, HIV-exposed Uninfected Infants: primary endpoint results, effect estimate with confidence interval, sample-size…
- HVTN 505Complete statistical analysis of HVTN 505, a randomized phase 2 trial of HIV-1 DNA plasmid and recombinant adenoviral vector vaccines in HIV-uninfected participants, including trial design, endpoints, Cox survival analyses, safety, and…
- HVTN 702Independent statistical analysis of HVTN 702, a randomized phase 2/3 HIV vaccine prevention trial evaluating ALVAC-HIV and bivalent subtype C gp120/MF59 versus placebo, including time-to-event methods, hazard ratios, confidence intervals, safety, and…
- HVTN119Independent statistical analysis of Safety and Immunogenicity of pDNA Vaccines Expressing HIV M Group p24^Gag Conserved Elements and/or p55^Gag, Administered With IL-12 pDNA: primary endpoint results, effect estimate with confidence interval, sample-size…
- HVTN702Independent statistical analysis of Pivotal Phase 2b/3 ALVAC/Bivalent gp120/MF59 HIV Vaccine Prevention Safety and Efficacy Study in South Africa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- HW005Independent statistical analysis of Clinical Evaluation of HW005 Ventricular Assist System for the Treatment of Advanced Heart Failure in Japan: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- HY-GRAIDIndependent statistical analysis of Yale-Harvard Hotel-based Closed-Loop Studies in Children (HY-GRAID): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04255381).
- Hyaluronidase Effect on Infusion Set Life: Complete Statistical AnalysisIndependent statistical analysis of Hyaluronidase Effect on Infusion Set Life: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02199028).
- HybridIndependent statistical analysis of A Comparison of Stryker Hybrid Arch Bars: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02283528).
- Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02463097).
- Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence: Complete Statistical AnalysisIndependent statistical analysis of Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01609842).
- HyCoSyIndependent statistical analysis of Can SIS Using Air Bubbles Replace HSG for Fallopian Tubal Patency After Essure Placement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Hydration Factor Study for the Stayhealthy BC3: Complete Statistical AnalysisIndependent statistical analysis of Hydration Factor Study for the Stayhealthy BC3: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01209936).
- Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00902538).
- Hydrocortisone for BPD: Complete Statistical AnalysisIndependent statistical analysis of Hydrocortisone for BPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01353313).
- Hydromorphone vs Fentanyl in Children Undergoing Tonsillectomy Surgery: Complete Statistical AnalysisIndependent statistical analysis of Hydromorphone vs Fentanyl in Children Undergoing Tonsillectomy Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04230681).
- Hydroxychloroquine and Cognitive Function After Surgery: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine and Cognitive Function After Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03025087).
- Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01573754).
- Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04372017).
- Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03275870).
- Hydroxychloroquine in Untreated B-CLL Patients: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine in Untreated B-CLL Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00771056).
- Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19): Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04318444).
- Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Hydroxychloroquine Versus Pioglitazone in Combination Treatment for Type 2 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine Versus Pioglitazone in Combination Treatment for Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HylenexIndependent statistical analysis of Descriptive Study of Cardiac Output During Rehydration With Recombinant Human Hyaluronidase in Pediatrics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Hyp-hOPIndependent statistical analysis of Brain-Centered Therapy Versus Medication for Urgency Urinary Incontinence : Hypnotherapy Or Pharmacotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HYPEIndependent statistical analysis of Avoidance of Hyperglycaemia in People With Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04732780).
- Hyperbaric Oxygen and Outcome After Below Knee Amputations: Complete Statistical AnalysisIndependent statistical analysis of Hyperbaric Oxygen and Outcome After Below Knee Amputations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04717557).
- Hyperbaric Oxygen for COVID-19 Patients: Complete Statistical AnalysisIndependent statistical analysis of Hyperbaric Oxygen for COVID-19 Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04332081).
- Hyperbaric Oxygen Therapy for Cognition in Diabetic Elderly at High Dementia Risk: Complete Statistical AnalysisIndependent statistical analysis of Hyperbaric Oxygen Therapy for Cognition in Diabetic Elderly at High Dementia Risk: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HYPERIONIndependent statistical analysis of Efficacy and Safety of Deferasirox in Combination With Deferoxamine Followed by Deferasirox Monotherapy in Severe Cardiac Iron Overload: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- HyperlinkIndependent statistical analysis of Home Blood Pressure Telemonitoring and Case Management to Control Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00781365).
- HYPEROXIA Responses and ROS: Complete Statistical AnalysisIndependent statistical analysis of HYPEROXIA Responses and ROS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05958303).
- hyperPOCIndependent statistical analysis of Comparison of hhCG With hCG+ß in the Early Prediction of Ongoing Pregnancy.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Hyperpolarized Xenon-129 Magnetic Resonance Imaging and Spectroscopy of Brown Fat: Healthy Adult Volunteer Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Hyperpolarized Xenon-129 Magnetic Resonance Imaging and Spectroscopy of Brown Fat: Healthy Adult Volunteer Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Hyperthermic Yoga for Depressive Symptoms: Complete Statistical AnalysisIndependent statistical analysis of Hyperthermic Yoga for Depressive Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02607514).
- Hypertonic Resuscitation Following Traumatic Injury: Complete Statistical AnalysisIndependent statistical analysis of Hypertonic Resuscitation Following Traumatic Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00316017).
- Hypertonic Saline for Acute Bronchiolitis: Complete Statistical AnalysisIndependent statistical analysis of Hypertonic Saline for Acute Bronchiolitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01247064).
- Hypnotherapy With Audiofiles for Children and Adolescents With Disorders of Gut-brain Interactions in Sweden -a Feasibility Study: Complete Statistical AnalysisIndependent statistical analysis of Hypnotherapy With Audiofiles for Children and Adolescents With Disorders of Gut-brain Interactions in Sweden -a Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- HypoANSIndependent statistical analysis of Hypoglycemia and Autonomic Nervous System Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01816893).
- Hypofractionated IMRT With Temozolomide for HGG: Complete Statistical AnalysisIndependent statistical analysis of Hypofractionated IMRT With Temozolomide for HGG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02082119).
- Hypofractionated Pre-operative Radiation Therapy for Soft Tissue Sarcomas of the Extremity and Chest-wall: Complete Statistical AnalysisIndependent statistical analysis of Hypofractionated Pre-operative Radiation Therapy for Soft Tissue Sarcomas of the Extremity and Chest-wall: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy: Complete Statistical AnalysisIndependent statistical analysis of Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before Surgery: Complete Statistical AnalysisIndependent statistical analysis of Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer: primary endpoint results, effect estimate with confidence…